rocuronium bromide

rocuronium bromide · ROCURONIUM BROMIDE 10 mg/mL · Solution · Intravenous · XGen Pharmaceuticals DJB, Inc.

NDC 39822-4200-02 · 10 VIAL in 1 CARTON / 5 mL in 1 VIAL · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price is down 25% over the past year, to $0.3942 per mL. It is in shortage right now. Put together: this is a fragile supply — if anything else goes wrong, there is very little slack to absorb it.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

9 price points · per ML · held since Invalid DateSource: CMS NADAC

Estimated fill cost

WAC per package, as filed

$45.00

Reported to Texas DSHS · 2025 annual filing · Xgen Pharmaceuticals Djb

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$755

513 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

63● High risk

Several kinds of pressure are visible at once — each line below is a condition that historically precedes supply trouble, and this market is stacking them.

2 active manufacturers+20
in shortage now+25
price down 25% year over year+8
sterile injectable+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for rocuronium bromide (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

Part D specialty tier
Costs ≥ $950/fill
Biologic (BLA)
Injectable / infused
Orphan-drug exclusivity
REMS program

Regulatory

Application: ANDA091115
TE code: AP
Approval date: Aug 27, 2012
Patents / exclusivity: None on file

Shortage history

In shortage now — Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 39822-4200-6)Feb 15, 2023
month 43 — 4× the typical 12-month other shortage
In shortage now — Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2)Feb 15, 2023
month 43 — 4× the typical 12-month other shortage

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of rocuronium bromide (Solution)

Labeler	Strength	First seen	Last seen
Medical Purchasing Solutions, LLC	ROCURONIUM BROMIDE 10 mg/mL	Jul 15, 2026	Sep 2, 2026
XGen Pharmaceuticals DJB, Inc.	ROCURONIUM BROMIDE 10 mg/mL	Jul 15, 2026	Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "rocuronium bromide — NDC 39822-4200-02," retrieved September 3, 2026, https://drugdashboards.com/drug/39822420002.

Free to cite with attribution — see how the data is put together.